All In MedTech

Device Trial Radar · NCT00206856

Rapid Assessment of Bedside BNP In Treatment of Heart Failure (RABBIT)

Last checked: Nov 20, 2026Latest source record: Jul 29, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedPivotal-lookingRandomized with 720 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

720

Actual

Start

Jul 2003

Primary completion

Apr 2006

Study completion Apr 2006

Sponsor

Lead sponsor
Abbott RDx CardiometabolicAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Sep 21, 2005

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Diagnostic
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To determine the clinical utility of using the Triage® BNP Test to guide therapy in outpatients with heart failure

Conditions

  • Heart Failure

Interventions

  • Triage® B-Type Natriuretic Peptide (BNP) TestDevice

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Combined endpoint of mortality, unplanned clinic or hospital visits that require IV treatment for heart failure, and quality of life.

Locations

29 sites in 1 country. Site status is shown where the registry gives one.

  • Scottsdale CardiovascularResearch

    Scottsdale, Arizona

28 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.